Avon (LON: AVON) won new contracts during the first half but they will probably not make much of a contribution in the six months to March 2020. The long-term outlook is positive, and the share price is more than one-quarter higher than at the start of the year.
All Avon’s factories appear to have stayed open and are producing normally with no indicated problems due to COVID-19.
Contracts have been won to supply side protection body armour plates and small arms protection inserts for the US. The former has a minimum value of $19m over an initial 18 months, although it could be worth a lot more, and the latter is worth $20m with deliveries starting in 2021.
There is also a $21m M69 aircrew mask order. Deliveries are starting this year.
Body armour and protection sales wi...